Pharma Pulse: TrumpRx Takes Flight and Novo Nordisk’s Super Bowl Gambit

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• The Trump administration has officially launched TrumpRx, a program centered on the most-favored nation pricing model. The platform offers MFN-aligned discounts via coupons for brand-name drugs, with 43 products listed and expansion anticipated across various categories, including fertility and anti-obesity GLP-1 therapies.
• Meanwhile, Novo Nordisk is making history. The Danish giant has secured its first-ever Super Bowl ad to promote the oral version of Wegovy, and is looking to dominate the metabolic market by highlighting the convenience of a pill over an injection. The commercial released on the morning of Feb. 6 uses both humor and celebrity appearances to challenge the notion that weight-loss medications represent “the easy way out.”

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.